AUG 24, 2020 2:46 PM PDT

Inhibiting Cancer Stem Cells to Stop Cancer Recurrence

WRITTEN BY: Jasper Cantrell

Once upon a time, stem cells were the talk of the town. They really are amazing, with some capable of turning into any other cell type. While most focus on how they can be used to heal, a more dangerous kind of stem cell, the cancer stem cell, also exists.

Cancer stem cells have become a significant research area, as they are thought to be important in the resurgence of cancer after surgery, chemotherapy, or radiotherapy. Although the initial treatment may have worked, cancer stem cells can lie dormant until activated by some signal.

A team from Lund University in Sweden had previously found that the molecule galiellalactone (GL), a STAT3 inhibitor, could stop the growth of prostate cancer cells and target them for elimination in early experiments. This new study sought to identify if galiellalactone could also affect cancer stem cells and cut off any resurgence before it starts.

They began by isolating cancer stem cells from a prostate cancer cell line and analyzing their characteristics. They saw that the stem cells had higher expression of markers of “stemness genes,” aka surface proteins that indicate if a cell is a cancer stem cell. The stem cells themselves behaved much like the prostate cancer cell line they originated from.

STAT3 is a protein that is critical to stem cell maturation. Upon application of galiellalactone, both the stem cells and parent cancer cells showed impaired growth. However, cancer stem cells were more sensitive to galiellalactone. Mouse models showed that prostate cancer tumors had decreased levels of “stemness genes,” although the team doesn’t note any changes to overall survival. One more test showed that galiellalactone was effective in reducing cellular growth of not only standard prostate cancer cells, but drug-resistant ones as well.

Inhibiting cancer stem cells’ activation is one of the most promising areas of research to stop the recurrence of cancer after treatment. While this study supported the molecule galiellalactone as a functional inhibitor of STAT3, many of the data suggest its growth suppression is not cancer stem cell-specific. The stem cells were more sensitive, though, which could point to galiellalactone as a possible therapy supplement against recurrence. Galiellalactone’s effects on drug-resistant prostate cancer cells is also a positive sign.

The study concludes, “Our findings here provide the first evidence that GL can target the CSCs in patient-derived primary prostate tumor cultures. We propose that the STAT3 inhibitor GL acts by reducing the viability of PCa-therapy-resistant cells in both CSCs and non-CSC populations.”

Sources: Nature Scientific Reports, Creative Diagnostics

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
AUG 06, 2020
Clinical & Molecular DX
Gut Feeling: Spotting the Early Signs of Gastric Cancer
AUG 06, 2020
Gut Feeling: Spotting the Early Signs of Gastric Cancer
In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leadi ...
AUG 13, 2020
Clinical & Molecular DX
A Call for Bigger, Better Studies on AI Breast Cancer Diagnostics
AUG 13, 2020
A Call for Bigger, Better Studies on AI Breast Cancer Diagnostics
A staggering 1 in 8 women in the U.S. will develop an aggressive form of breast cancer in their lifetime, making it the ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
SEP 21, 2020
Cancer
Black women have delayed and longer breast cancer treatment
SEP 21, 2020
Black women have delayed and longer breast cancer treatment
A study led by UNC Lineberger Comprehensive Cancer Center researchers has quantified the healthcare inequities in cancer ...
SEP 29, 2020
Cancer
Gut microbiome influences oral therapy for prostate cancer treatment
SEP 29, 2020
Gut microbiome influences oral therapy for prostate cancer treatment
Research from a team of scientists at Lawson Health Research Institute and Western University suggests that bacteria in ...
OCT 08, 2020
Cancer
Oral cancer pain levels indicate metastasis
OCT 08, 2020
Oral cancer pain levels indicate metastasis
A new study from NYU College of Dentistry researchers provides insight as to why patients with metastatic oral cancer ex ...
Loading Comments...